tirzepatide better than retatrutide vs. Retatrutide: Key Differences Explained Retatrutide vs Tirzepatide: Which Is

More important than my observation is the following: In comments by Thompson and Sturmer published in the journal Diabetes Care in 2023, about a study of GLP-1s and the risk of thyroid cancer conducted by Bezin et al which was published in the same journal issue, Thompson and Sturmer conclude that Thyroid cancer is a rare outcome, however, and the potential increase in absolute risk is very small

At 24 weeks, a statistically significant reduction in A1C occurred in all treatment groups ( P .0001), compared to the metformin plus placebo group

Rezaie et al

n diffusional exponent

As obesity & diabetes markets blur, could we see combination therapies or even next-gen triple agonists